Chronic Kidney Disease Trial, Recruiting NCT04759274 Sponsor: University of Texas Southwestern Medical Center Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT04759274
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have high levels of protein in their urine (above a certain threshold, measured by a urine test) OR have significantly reduced kidney function (stage 4 or 5 chronic kidney disease), AND
  • People who are showing signs of fluid build-up in their body — such as swelling in the legs, fluid in the abdomen, or fluid around the lungs — and whose current body weight is at least 5 pounds above their estimated normal "dry" weight (the weight they would be at without that excess fluid)

Who may not be able to join:

  • People who weigh less than 100 pounds or more than 300 pounds
  • People who have a condition affecting their nervous system that causes their blood pressure to drop when they stand up
  • People with low potassium levels in their blood at the time of enrolment
  • People with moderately or severely low sodium levels in their blood at the time of enrolment
  • People with creatinine levels in their blood above a certain threshold, or significantly elevated compared to their usual baseline level (confirm with trial site)
  • People who are unable or unwilling to regularly check and record their blood pressure and weight at home
  • People who do not have a working phone number or a smartphone
  • People for whom doctors expect dialysis will be needed within 3 months
  • People with a life expectancy of less than 6 months
  • People living with a condition that would make it difficult to use the trial's digital tool, such as dementia, being unable to read, or blindness
  • People who are pregnant
  • People who are currently incarcerated

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 214-645-6190

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 November 2023
Est. completion
1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mean time to the attainment of dry weight; 90 day weight variability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov